Same Mutation, Different Fate

When MRD testing evolves from a numerical readout into a definition of clonal behavior, it becomes what clinicians have needed all along: a tool that informs action, not just detection. The post Same Mutation, Different Fate appeared first on MedCity News.

Read More

Why 31,000 Kaiser Permanente Workers Are Striking — Again

About 31,000 Kaiser Permanente healthcare workers plan to launch an open-ended strike over staffing shortages, wages and care access issues — potentially affecting dozens of hospitals and hundreds of clinics in California and Hawaii. While Kaiser blames unions for stalled negotiations, workers say the conflict reflects deeper concerns about patient safety, burnout and health systems’…

Read More

Neuroscience Biotech Alkermes Sees Narcolepsy R&D as Launchpad for a Range of New Fatigue Therapies

Alkermes is chasing Takeda Pharmaceutical, whose orexin receptor-targeting pill is on track to become first in a new class of narcolepsy medicines. Blair Jackson, chief operating officer of the neuroscience biotech, says Alkermes’s drug offers advantages and also paves the way to bring orexin agonism to other indications. The post Neuroscience Biotech Alkermes Sees Narcolepsy…

Read More